The World Association on Dual Disorders (WADD), the World Psychiatric Association (WPA) (Section on Dual Disorders), and the Sociedad Española de Patología Dual (SEPD) have joined forces to clarify that:
Addiction is a mental disorder, not a voluntary, self-indulgent act.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Association. doi: 10.1176/appi.books.9780890425596.744053
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babín, F. (2013). Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services. Adicciones, 25(2), 118-27. doi: 10.1080/17523281.2012.748674
Greenfield, S. F., & Weiss, R. D. (2015). Harvard Review of Psychiatry: Introduction. Harvard Review of Psychiatry, 23(2), 61-62. doi: 10.1097/HRP.0000000000000074
Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N., Winters, K. C., & Shaffer, H. J. (2008). DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychological Medicine, 38(9), 1351-1360. doi: 10.1017/S0033291708002900
Lev-Ran, S., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal on Addictions, 22(2), 93-98. doi:10.1111/j.1521-0391.2013.00304.x
Leyton, M., & Vezina, P. (2014). Dopamine ups and downs in vulnerability to addictions: A neurodevelopmental model. Trends in Pharmacological Sciences. doi: 10.1016/j.tips.2014.04.002
Mann, K., Roos, C., Hoffmann, S., Nakovics, H., Leméganer, T., Heinz, A., & Wictiewitz, K. (2017). Precision medicine in alcohol dependence: A controlled trial testing pharmacotherapy response among reward an relief dinking phenotype. Neuropsychopharmacology. Retrieved from: https://www.nature.com/articles/npp2017282
Minkoff, K. (2001). Best Practices: Developing Standards of Care for Individuals With Co-occurring Psychiatric and Substance Use Disorders. Psychiatric Services, 52(5), 597-599. doi: 10.1176/appi.ps.52.5.597
National Institute on Drug Abuse. (2007). Addiction and co-occurring mental disorders.
Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., … & Grau-López, L. (2016). Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174-181. doi: 10.1016/j.psychres.2016.06.024
Szerman, N., & Martinez-Raga, J. (2015). Editorial. Advances in Dual Diagnosis, 8(2). doi: 10.1108/ADD-03-2015-0004
Szerman, N., Martinez-raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1). doi: 10.1097/ADT.0b013e31826e7b6a
Van Os, J., Delespaul, P., Wigman, J., Myin-Germeys, I., & Wichers, M. (2013). Beyond DSM and ICD: Introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry, 12(2), 113-117. doi: 10.1002/wps.20046
Volkow, N. D. (2001). Drug abuse and mental illness: Progress in understanding comorbidity. American Journal of Psychiatry, 158(8), 1181-1183. doi: 10.1176/appi.ajp.158.8.1181
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. The New England Journal of Medicine, 374(4), 363-371. doi: 10.1056/NEJMra1511480